Search results for "Highlights"
Review finds only two efficacious medications to treat gastroparesis
Clebopride ranked first for efficacy, followed by domperidone, and no other drug was superior to placebo for improving symptoms of gastroparesis, according to a recent meta-analysis.
https://gastroenterology.acponline.org/archives/2023/01/27/2.htm
27 Jan 2023
NASH management conflicts with guidelines in real-world setting, study finds
Researchers sought to learn how patient characteristics vary by stages of liver scarring and how U.S. physicians manage nonalcoholic steatohepatitis (NASH).
https://gastroenterology.acponline.org/archives/2023/05/26/2.htm
26 May 2023
Rise in liver disease deaths not fully explained by metabolic syndrome or alcohol use
An analysis of the prevalence of metabolic syndrome and alcohol use in the U.S. between 1999 and 2018 found that while the proportion of patients with metabolic syndrome and nonheavy alcohol use grew the most, liver disease increased the most among those who drank heavily.
https://gastroenterology.acponline.org/archives/2023/05/26/3.htm
26 May 2023
IBD patients may be at higher risk for CKD
A Swedish study found that 11.8% of patients with inflammatory bowel disease (IBD) were diagnosed with chronic kidney disease (CKD) within 10 years, and their risks of acute kidney injury and kidney stones were also elevated.
https://gastroenterology.acponline.org/archives/2023/08/25/2.htm
25 Aug 2023
Rates of pancreatic cancer rising, particularly among younger women
Among women ages 15 to 34 years, pancreatic cancer incidence rates rose by 6.45% per year in 2001 to 2018, according to a study using nationwide data covering about two-thirds of the U.S. population.
https://gastroenterology.acponline.org/archives/2023/02/24/3.htm
24 Feb 2023
Defensiveness may help explain limited uptake of FIT, Irish study finds
Patients who declined an invitation to fecal immunochemical testing (FIT) scored higher on a measure of defensive information processing, indicating that certain psychological approaches may be more likely to increase screening uptake.
https://gastroenterology.acponline.org/archives/2023/02/24/2.htm
24 Feb 2023
Healthy lifestyle may mitigate genetic risk for inflammatory bowel disease
In a cohort study, U.K. residents with high genetic risk for inflammatory bowel disease who met four or five lifestyle measures developed Crohn's disease or ulcerative colitis at higher-than-average rates, but at about half the rate of those with both genetic risk and an unhealthy lifestyle.
https://gastroenterology.acponline.org/archives/2023/01/27/3.htm
27 Jan 2023
Risk for CRC with young-onset adenomas may vary by stage
A cohort study in U.S. veterans younger than age 50 years found that those with advanced adenomas had an eightfold increased risk for incident colorectal cancer (CRC) versus those with normal results, whereas cumulative CRC incidence and mortality at 10 years were relatively low overall.
https://gastroenterology.acponline.org/archives/2023/04/21/3.htm
21 Apr 2023
In adults using oral anticoagulants, PPI use may be associated with lower risk for upper GI bleeding
An ACP Journal Club commentary on the meta-analysis stressed the importance of assessing patients' underlying risk for GI bleeding and using overall clinical risk to guide shared decision making in those at higher risk or with lower baseline bleeding tolerance.
https://gastroenterology.acponline.org/archives/2022/11/18/9.htm
18 Nov 2022
Guidance offered on management of extraesophageal GERD
The clinical practice update from the American Gastroenterological Association was based on a review of the evidence and expert opinion regarding extraesophageal symptoms of gastroesophageal reflux disease (GERD).
https://gastroenterology.acponline.org/archives/2023/04/21/2.htm
21 Apr 2023